In Budget 2025, the Madani Government increased its allocation for the Ministry of Health by 10% to 43.5 billion ringgit. So how will this benefit pharmaceutical players like Duopharma Biotech Bhd that rely heavily on government procurements? We discuss the company’s fortunes and prospects with Group Managing Director Leonard Ariff.
Image Credit: Duopharma Biotech Berhad

Czechia’s Global Balancing Act
22:50

MUDA’s Leadership Transition And Strategy Ahead of GE16
32:20

Solarvest: Built for the Long Horizon
24:18